1. Home
  2. AVDL vs AXGN Comparison

AVDL vs AXGN Comparison

Compare AVDL & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • AXGN
  • Stock Information
  • Founded
  • AVDL 2015
  • AXGN N/A
  • Country
  • AVDL Ireland
  • AXGN United States
  • Employees
  • AVDL N/A
  • AXGN N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AVDL Health Care
  • AXGN Health Care
  • Exchange
  • AVDL Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • AVDL 786.3M
  • AXGN 798.3M
  • IPO Year
  • AVDL 1996
  • AXGN N/A
  • Fundamental
  • Price
  • AVDL $7.64
  • AXGN $18.41
  • Analyst Decision
  • AVDL Strong Buy
  • AXGN Strong Buy
  • Analyst Count
  • AVDL 6
  • AXGN 3
  • Target Price
  • AVDL $20.00
  • AXGN $16.00
  • AVG Volume (30 Days)
  • AVDL 1.7M
  • AXGN 575.3K
  • Earning Date
  • AVDL 03-03-2025
  • AXGN 03-04-2025
  • Dividend Yield
  • AVDL N/A
  • AXGN N/A
  • EPS Growth
  • AVDL N/A
  • AXGN N/A
  • EPS
  • AVDL N/A
  • AXGN N/A
  • Revenue
  • AVDL $138,160,000.00
  • AXGN $180,855,000.00
  • Revenue This Year
  • AVDL $515.63
  • AXGN $19.15
  • Revenue Next Year
  • AVDL $49.32
  • AXGN $12.92
  • P/E Ratio
  • AVDL N/A
  • AXGN N/A
  • Revenue Growth
  • AVDL 1523.50
  • AXGN 18.79
  • 52 Week Low
  • AVDL $7.39
  • AXGN $5.55
  • 52 Week High
  • AVDL $19.09
  • AXGN $19.06
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 30.42
  • AXGN 60.92
  • Support Level
  • AVDL $7.40
  • AXGN $17.60
  • Resistance Level
  • AVDL $8.01
  • AXGN $19.06
  • Average True Range (ATR)
  • AVDL 0.44
  • AXGN 1.02
  • MACD
  • AVDL -0.07
  • AXGN -0.02
  • Stochastic Oscillator
  • AVDL 6.93
  • AXGN 87.15

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: